Genome-Wide Assessment of Differential DNA Methylation Associated with Autoantibody Production in Systemic Lupus Erythematosus.

Systemic lupus erythematosus (SLE) is characterized by the development of autoantibodies associated with specific clinical manifestations. Previous studies have shown an association between differential DNA methylation and SLE susceptibility, but have not investigated SLE-related autoantibodies. Our...

Full description

Bibliographic Details
Main Authors: Sharon A Chung, Joanne Nititham, Emon Elboudwarej, Hong L Quach, Kimberly E Taylor, Lisa F Barcellos, Lindsey A Criswell
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4508022?pdf=render
_version_ 1819239390236377088
author Sharon A Chung
Joanne Nititham
Emon Elboudwarej
Hong L Quach
Kimberly E Taylor
Lisa F Barcellos
Lindsey A Criswell
author_facet Sharon A Chung
Joanne Nititham
Emon Elboudwarej
Hong L Quach
Kimberly E Taylor
Lisa F Barcellos
Lindsey A Criswell
author_sort Sharon A Chung
collection DOAJ
description Systemic lupus erythematosus (SLE) is characterized by the development of autoantibodies associated with specific clinical manifestations. Previous studies have shown an association between differential DNA methylation and SLE susceptibility, but have not investigated SLE-related autoantibodies. Our goal was to determine whether DNA methylation is associated with production of clinically relevant SLE-related autoantibodies, with an emphasis on the anti-dsDNA autoantibody. In this study, we characterized the methylation status of 467,314 CpG sites in 326 women with SLE. Using a discovery and replication study design, we identified and replicated significant associations between anti-dsDNA autoantibody production and the methylation status of 16 CpG sites (pdiscovery<1.07E-07 and preplication<0.0029) in 11 genes. Associations were further investigated using multivariable regression to adjust for estimated leukocyte cell proportions and population substructure. The adjusted mean DNA methylation difference between anti-dsDNA positive and negative cases ranged from 1.2% to 19%, and the adjusted odds ratio for anti-dsDNA autoantibody production comparing the lowest and highest methylation tertiles ranged from 6.8 to 18.2. Differential methylation for these CpG sites was also associated with anti-SSA, anti-Sm, and anti-RNP autoantibody production. Overall, associated CpG sites were hypomethylated in autoantibody positive compared to autoantibody negative cases. Differential methylation of CpG sites within the major histocompatibility region was not strongly associated with autoantibody production. Genes with differentially methylated CpG sites represent multiple biologic pathways, and have not been associated with autoantibody production in genetic association studies. In conclusion, hypomethylation of CpG sites within genes from different pathways is associated with anti-dsDNA, anti-SSA, anti-Sm, and anti-RNP production in SLE, and these associations are not explained by genetic variation. Thus, studies of epigenetic mechanisms such as DNA methylation represent a complementary method to genetic association studies to identify biologic pathways that may contribute to the clinical heterogeneity of autoimmune diseases.
first_indexed 2024-12-23T13:51:21Z
format Article
id doaj.art-b3afaae54ea74242a2e6572ee826cc8c
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-23T13:51:21Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-b3afaae54ea74242a2e6572ee826cc8c2022-12-21T17:44:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01107e012981310.1371/journal.pone.0129813Genome-Wide Assessment of Differential DNA Methylation Associated with Autoantibody Production in Systemic Lupus Erythematosus.Sharon A ChungJoanne NitithamEmon ElboudwarejHong L QuachKimberly E TaylorLisa F BarcellosLindsey A CriswellSystemic lupus erythematosus (SLE) is characterized by the development of autoantibodies associated with specific clinical manifestations. Previous studies have shown an association between differential DNA methylation and SLE susceptibility, but have not investigated SLE-related autoantibodies. Our goal was to determine whether DNA methylation is associated with production of clinically relevant SLE-related autoantibodies, with an emphasis on the anti-dsDNA autoantibody. In this study, we characterized the methylation status of 467,314 CpG sites in 326 women with SLE. Using a discovery and replication study design, we identified and replicated significant associations between anti-dsDNA autoantibody production and the methylation status of 16 CpG sites (pdiscovery<1.07E-07 and preplication<0.0029) in 11 genes. Associations were further investigated using multivariable regression to adjust for estimated leukocyte cell proportions and population substructure. The adjusted mean DNA methylation difference between anti-dsDNA positive and negative cases ranged from 1.2% to 19%, and the adjusted odds ratio for anti-dsDNA autoantibody production comparing the lowest and highest methylation tertiles ranged from 6.8 to 18.2. Differential methylation for these CpG sites was also associated with anti-SSA, anti-Sm, and anti-RNP autoantibody production. Overall, associated CpG sites were hypomethylated in autoantibody positive compared to autoantibody negative cases. Differential methylation of CpG sites within the major histocompatibility region was not strongly associated with autoantibody production. Genes with differentially methylated CpG sites represent multiple biologic pathways, and have not been associated with autoantibody production in genetic association studies. In conclusion, hypomethylation of CpG sites within genes from different pathways is associated with anti-dsDNA, anti-SSA, anti-Sm, and anti-RNP production in SLE, and these associations are not explained by genetic variation. Thus, studies of epigenetic mechanisms such as DNA methylation represent a complementary method to genetic association studies to identify biologic pathways that may contribute to the clinical heterogeneity of autoimmune diseases.http://europepmc.org/articles/PMC4508022?pdf=render
spellingShingle Sharon A Chung
Joanne Nititham
Emon Elboudwarej
Hong L Quach
Kimberly E Taylor
Lisa F Barcellos
Lindsey A Criswell
Genome-Wide Assessment of Differential DNA Methylation Associated with Autoantibody Production in Systemic Lupus Erythematosus.
PLoS ONE
title Genome-Wide Assessment of Differential DNA Methylation Associated with Autoantibody Production in Systemic Lupus Erythematosus.
title_full Genome-Wide Assessment of Differential DNA Methylation Associated with Autoantibody Production in Systemic Lupus Erythematosus.
title_fullStr Genome-Wide Assessment of Differential DNA Methylation Associated with Autoantibody Production in Systemic Lupus Erythematosus.
title_full_unstemmed Genome-Wide Assessment of Differential DNA Methylation Associated with Autoantibody Production in Systemic Lupus Erythematosus.
title_short Genome-Wide Assessment of Differential DNA Methylation Associated with Autoantibody Production in Systemic Lupus Erythematosus.
title_sort genome wide assessment of differential dna methylation associated with autoantibody production in systemic lupus erythematosus
url http://europepmc.org/articles/PMC4508022?pdf=render
work_keys_str_mv AT sharonachung genomewideassessmentofdifferentialdnamethylationassociatedwithautoantibodyproductioninsystemiclupuserythematosus
AT joannenititham genomewideassessmentofdifferentialdnamethylationassociatedwithautoantibodyproductioninsystemiclupuserythematosus
AT emonelboudwarej genomewideassessmentofdifferentialdnamethylationassociatedwithautoantibodyproductioninsystemiclupuserythematosus
AT honglquach genomewideassessmentofdifferentialdnamethylationassociatedwithautoantibodyproductioninsystemiclupuserythematosus
AT kimberlyetaylor genomewideassessmentofdifferentialdnamethylationassociatedwithautoantibodyproductioninsystemiclupuserythematosus
AT lisafbarcellos genomewideassessmentofdifferentialdnamethylationassociatedwithautoantibodyproductioninsystemiclupuserythematosus
AT lindseyacriswell genomewideassessmentofdifferentialdnamethylationassociatedwithautoantibodyproductioninsystemiclupuserythematosus